Search

Reset

Searching with a thematic focus on Intellectual Property Rights, Trade Policy

Showing 311-320 of 420 results

Pages

  • Document

    Guiding principles for biodiversity in development: lessons from field projects

    World Commission on Protected Areas, 2001
    Capturing the experiences and opinions of people working on biodiversity issues in some 35 EU partner countries.
  • Document

    Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries (4th Edition)

    Access to Essential Medicines Campaign, MSF, 2003
    The data in this guide on ARV prices offered by originator companies and some generic companies in low- and middle-income countries are meant to provide potential buyers with clear verified data. This information is intended for use by government and non-profit procurement agencies, as well as other bulk purchasers of ARVs, including health facilities and non governmental organizations (NGOs).
  • Document

    Responding to market failures in tuberculosis control

    Access to Essential Medicines Campaign, MSF, 2001
    This report evaluates the success of a programme to negotiate cost reductions in TB drugsThe specter of multidrug-resistant tuberculosis (MDR-TB) threatens the gains achieved by tuberculosis control through international recommendations currently accepted by 127 countries.
  • Document

    Fatal imbalance: the crisis in research and development for drugs for neglected diseases

    Médecins Sans Frontières, 2001
    The human suffering caused by infectious diseases could be reduced; with billions of dollars dedicated to health research and development (R&D) it should be possible to develop effective treatments for these diseases. However, the lack of R&D for diseases common in developing countries means that very few new drugs have been brought to market for them.
  • Document

    The strengthening of IPRs in developing countries and complimentary legislation

    Department for International Development, UK, 2001
    This paper considers areas of legislation and aspects relating to the implementation of IPRs that should accompany the introduction or reform of IPRs laws in developing countries.
  • Document

    Intellectual property rights and human rights: report of the Secretary-General

    United Nations [UN] High Commission for Refugees, 2001
    Paper presents the positions of a variety of international organisations and non-governmental organisations (as of 29 May 2001) from:BrazilPakistanUnited Nations Conference on Trade and DevelopmentWorld Trade OrganisationCenter for International Environmental LawEuropean Writers' CongressGreenpeacethe German Peace and Justice CommissionInternational Associat
  • Document

    The impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights on human rights: report of the High Commissioner

    United Nations [UN] High Commission for Refugees, 2001
    This report examines the role of the TRIPS Agreement on the promotion and protection of the right to health. It focuses on the right to health as an entry point for an analysis of the TRIPS Agreement for several reasons. First, resolution 2000/7 recognises that the TRIPS Agreement could affect the enjoyment of the right to health - in particular through its effect on access to pharmaceuticals.
  • Document

    Brazil to bypass patent on costly AIDS drug

    Ethics Newsline, Institute for Global Ethics, 2001
    Brazil's health minister announced last week (gone to press on the 23 Aug) that the government would break the patent of a leading anti-AIDS drug after its manufacturer, Hoffman-La Roche Inc., refused to lower its price to the level demanded by the government.Brazilian law allows a patent to be overridden if the government claims the patent holder is abusing its monopoly or in cases of national
  • Document

    Regulatory standards in the WTO: comparing intellectual property rights with competition policy, environmental protection, and core labor standards

    Institute for International Economics, USA, 2000
    Paper addresses the question of whether regulatory and process standards, including competition policy, environmental standards, and worker rights, should be placed onto the WTO agenda. Because they evidently no longer may be excluded on the grounds of the inability of the trading system to discipline process standards, the argument must proceed on other grounds.
  • Document

    Protection of traditional medicine

    Commission on Macroeconomics and Health, WHO, 2001
    Paper emphasises the importance of the protection of traditional medicine. It gives a definition of traditional knowledge, with particular emphasis on traditional medicine and examines the role of traditional medicine - in particular in respect of products that may have applications in the treatment of disease outside of the local context in which the traditional medicines were developed.

Pages